Skip to main content

Patel Sanj K's Form 4 filing

Kiniksa Pharmaceuticals International, plc (KNSA) · filed Oct 22, 2025

Accession no.
0001532218-25-000005
Filed
Oct 22, 2025
Trade date
Oct 20-22, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $10.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Patel Sanj KCIK 0001532218Director, Officer (CHAIRMAN & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+121,248$3.80+$460,742.4233,042Direct
Oct 20, 2025Class A Ordinary ShareSSaleDisposed−98,934$38.81−$3,839,628.54134,108Direct
Oct 20, 2025Class A Ordinary ShareSSaleDisposed−22,314$39.32−$877,386.48111,794Direct
Oct 21, 2025Class A Ordinary ShareMOption exerciseAcquired+39,331$3.80+$149,457.8151,125Direct
Oct 21, 2025Class A Ordinary ShareSSaleDisposed−39,331$38.77−$1,524,862.87111,794Direct
Oct 22, 2025Class A Ordinary ShareMOption exerciseAcquired+97,390$3.80+$370,082209,184Direct
Oct 22, 2025Class A Ordinary ShareSSaleDisposed−97,390$38.83−$3,781,653.7111,794Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−121,248$0.00$0136,721Direct
Oct 21, 2025Class A Ordinary ShareMOption exerciseDisposed−39,331$0.00$097,390Direct
Oct 22, 2025Class A Ordinary ShareMOption exerciseDisposed−97,390$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)